Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
The study on the use of subcutaneous racemic ketamine in treatment-resistant depression underscores the significance of a flexible, individualized dosing approach over a 4-week course.
Psychiatry August 2nd 2023
Exploring new avenues for treating depression in youth, this compelling research showcases the potential of physical activity interventions in significantly reducing depressive symptoms, particularly among those aged 13 years and above. Find out how this accessible, non-pharmacological approach could transform pediatric mental health care.
Pediatrics July 26th 2023
Explore the recent identification of two distinct neurophysiological subtypes of major depressive disorder, a key advancement that could refine your approach to personalized treatments in mental health.
Psychiatry July 19th 2023
MDLinx
Emerging from the University of Exeter, augmented depression therapy (ADepT) proposes a novel approach in depression treatment, potentially surpassing the current gold standard, cognitive behavioral therapy (CBT), in both efficacy and cost-efficiency. This ground-breaking therapy, focusing on both symptom reduction and well-being enhancement, offers promising implications for the future of mental health care.
Psychiatry Advisor
With a reported quarter of perinatal women in low and middle-income countries experiencing depression, the spotlight is on the global healthcare community to strategize and implement effective mental health interventions. This landmark study signals a pressing need to address this silent epidemic.
Psychiatry June 28th 2023
Psychiatrist.com
Explore the results of this study, which shed light on the underreported and frequently misunderstood phenomena of “brain zaps” during antidepressant withdrawal and its effects on medicine use and quality of life.